Ohmi, Yuhsuke
Ise, Wataru
Harazono, Akira
Takakura, Daisuke
Fukuyama, Hidehiro
Baba, Yoshihiro
Narazaki, Masashi
Shoda, Hirofumi
Takahashi, Nobunori
Ohkawa, Yuki
Ji, Shuting
Sugiyama, Fumihiro
Fujio, Keishi
Kumanogoh, Atsushi
Yamamoto, Kazuhiko
Kawasaki, Nana
Kurosaki, Tomohiro
Takahashi, Yoshimasa
Furukawa, Koichi
Article History
Received: 21 October 2015
Accepted: 2 March 2016
First Online: 5 April 2016
Competing interests
: K.Y. received financial support or fees from AbbVie, Asahi Kasei, Astellas, BMS, Boehringer Ingelheim, Daiichi-Sankyo, ImmunoFuture, Janssen, MitsubishiTanabe, Pfizer, Sanofi, Santen, Takeda, Teijin, Chugai, Eisai, Ono Taisho Toyama and UCB. K.F. received financial support or fees from Astellas, BMS, Chugai, Daiichi-Sankyo, Eisai, Janssen, MitsubishiTanabe, Pfizer, Santen, Takeda, Taisho Toyama and UCB. The remaining authors declare no competing financial interests.